To empower people who are living with hepatitis C and raise awareness of the virus in the wider community; by providing quality information, support and education enabling everyone to make informed choices for their health and well-being.
Information about Pegasys (Pegylated interferon alfa-2a)
Information about Peginterferon alfa-2a the Drug that is approved around the world for the treatment of chronic hepatitis C can be found at http://www.pegasys.co.nz/.
World Hepatitis Day is an annual event that each year provides international focus for patient groups and people living with hepatitis B and C. It is an opportunity around which interested groups can raise awareness and influence real change in disease prevention and access to testing and treatment.
The World Hepatitis Alliance first launched World Hepatitis Day in 2008, and since then thousands of events have taken place around the world, generating massive public and media interest. The Alliance has also received support from governments worldwide, high-profile Non-Governmental Organisations (NGOs) and supranational bodies, such as Médecins Sans Frontières.
Following the World Health Assembly in May 2010, it was agreed that World Hepatitis Day would be recognised annually on 28 July.